Ike Swetlitz

Amgen Inc.’s third-quarter profit beat Wall Street estimates as the company’s expenses were lower than anticipated.

CVS Health Corp.’s new Chief Executive Officer David Joyner offered investors no guidance on the company’s expected financial performance for 2024 or 2025 in Wednesday’s earnings report, the first of his tenure.

CVS Health Corp.'s new Chief Executive Officer David Joyner offered investors no guidance on the company's expected financial performance for 2024 or 2025 in Wednesday's earnings report, the first of his tenure.

Steve Nelson will have to grapple with the rising medical costs and decreased government payments that crimped the unit's returns.

(Bloomberg) -- CVS Health Corp.’s new Chief Executive Officer David Joyner offered investors no guidance on the company’s expected financial performance for 2024 or 2025 in Wednesday’s earnings report, the first of his tenure.Most Read from BloombergParis Restricts Through Traffic in City CenterFrom Housing to Immigration, Key Ballot Initiatives and Local Races to FollowKey Ballot Initiatives and Local Races Highlight Views on Abortion, ImmigrationThe company did announce a new president for its

Hi, it’s Ike in Boston. Hospitals everywhere are running low on intravenous fluids and finding creative ways to keep taking care of patients. More on that later, but first …

Hi, it’s Ike in Boston. Today I have a rare bit of good news — sexually transmitted infections in the US decreased in 2023. More on that soon, but first ...

CVS has withdrawn its guidance for this year and offered investors no outlook for the next amid struggles in both the pharmacy and insurance businesses. In September, CVS executives met with Glenview, which had accumulated a stake of about $700 million and was pushing for change.

(Bloomberg) -- CVS Health Corp. named Glenview Capital Management founder Larry Robbins to its board as part of an agreement with the activist firm that's been pressuring the company for change.

CVS Health Corp. named Glenview Capital Management founder Larry Robbins to its board as part of an agreement with the activist firm that's been pressuring the company for change.